Scott Novak appointed to FDA External Scientific Advisory Board

RESEARCH TRIANGLE PARK, NC – The Food and Drug Administration Center for Drug Evaluation and Research appointed Scott Novak, Ph.D., senior developmental epidemiologist at RTI International, to serve on the Scientific Advisory Board.

Novak will act as a scientific advisor on behalf of the Office of Surveillance and Epidemiology, and will serve as a member of the Drug Safety and Risk Management Advisory Committee. His appointment begins on June 1 and launches a four-year term.

The Drug Safety and Risk Management Advisory Committee consist of external experts who advise the FDA on issues related to drugs, tobacco products, biological agents and medical devices. The committee also conducts ongoing reviews of agency priorities and approves funding decisions for grants and contracts supported by the FDA.  

At RTI, Novak leads federally funded studies that look at the onset and course of prescription drug abuse as well as attitudes and consumption practices of medical marijuana patients in the United States. He actively investigates the epidemiology of prescription drugs and new synthetic/designer drugs that are abused in the United States and internationally.

He will moderate RTI's upcoming policy forum that will explore the positive and negative consequences of marijuana legalization at the National Press Club in Washington, D.C., May 20 

Additionally, he recently completed a large international study to examine the prevalence of prescription drug abuse, alcohol, tobacco, and marijuana among adolescents and adults in the European Union. Novak also leads a data-coordinating center from the Substance Abuse and Mental Health Services Administration to track performance measures for clients in 600 substance abuse treatment facilities across the United States. Before coming to RTI in 2004, he was on the faculty of Brown University in the Department of Community Health, and was a Robert Wood Johnson Faculty Fellow in the Department of Health Care Policy/Maternal and Child Health at Harvard University.

Novak holds a doctorate in quantitative sociology and a master's in medical sociology from University of Kentucky at Lexington, a master's in statistics from Harvard University and a bachelor's degree in statistics as well as sociology from the University of Wisconsin at Madison.

 

Highlights

  • The FDA Center for Drug Evaluation and Research appointed Scott Novak to serve on the Scientific Advisory Board
  • Novak will advise the Office of Surveillance and Epidemiology, and serve on Drug Safety and Risk Management Advisory Committee